MedTrace Logo

Diagnostic Immunization With Rabies Vaccine in Patients With PID

NCT02490956 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2015-07-07

No results posted yet for this study

Summary

The purpose of this study is to evaluate diagnostic immunization protocol of rabies vaccine for diagnosis the patients with primary immunodeficiency disorders and study humoral and cellular immune response to rabies vaccine in patients with primary immunodeficiency.

Conditions

  • Primary Immunodeficiency

Interventions

BIOLOGICAL

Verorab® (PVRV; Purified Vero Cell Vaccine)

* Verorab® (PVRV; Purified Vero Cell Vaccine) 0.5 ml intramuscular * Standard intramuscular regimen: ESSEN on days 0, 3, 7, 14, 28 and booster at 1 year later on days 360 and 363

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Narissara - Suratannon, MD · Chulalongkorn University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Months
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02490956 on ClinicalTrials.gov